The cancer proteomic landscape and the HUPO Cancer Proteome Project

Connie R. Jimenez, Hui Zhang, Christopher R. Kinsinger, Edouard C. Nice

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

The Human Cancer Proteome Project (Cancer-HPP) is an international initiative organized by HUPO whose key objective is to decipher the human cancer proteome through a coordinated effort by cancer proteome researchers around the world. The ultimate goal is to map the entire human cancer proteome to disclose tumor biology and drive improved diagnostics, treatment and management of cancer. Here we report the progress in the cancer proteomics field to date, and discuss future proteomic developments that will be needed to optimally delineate cancer phenotypes and advance the molecular characterization of this significant disease that is one of the leading causes of death worldwide.
Original languageEnglish
Article number4
JournalClinical Proteomics
Volume15
Issue number1
DOIs
Publication statusPublished - 2018

Cite this

Jimenez, Connie R. ; Zhang, Hui ; Kinsinger, Christopher R. ; Nice, Edouard C. / The cancer proteomic landscape and the HUPO Cancer Proteome Project. In: Clinical Proteomics. 2018 ; Vol. 15, No. 1.
@article{48e1b2a1d47c45aca58551a706e4b52e,
title = "The cancer proteomic landscape and the HUPO Cancer Proteome Project",
abstract = "The Human Cancer Proteome Project (Cancer-HPP) is an international initiative organized by HUPO whose key objective is to decipher the human cancer proteome through a coordinated effort by cancer proteome researchers around the world. The ultimate goal is to map the entire human cancer proteome to disclose tumor biology and drive improved diagnostics, treatment and management of cancer. Here we report the progress in the cancer proteomics field to date, and discuss future proteomic developments that will be needed to optimally delineate cancer phenotypes and advance the molecular characterization of this significant disease that is one of the leading causes of death worldwide.",
author = "Jimenez, {Connie R.} and Hui Zhang and Kinsinger, {Christopher R.} and Nice, {Edouard C.}",
year = "2018",
doi = "10.1186/s12014-018-9180-6",
language = "English",
volume = "15",
journal = "Clinical Proteomics",
issn = "1542-6416",
publisher = "BioMed Central Ltd.",
number = "1",

}

The cancer proteomic landscape and the HUPO Cancer Proteome Project. / Jimenez, Connie R.; Zhang, Hui; Kinsinger, Christopher R.; Nice, Edouard C.

In: Clinical Proteomics, Vol. 15, No. 1, 4, 2018.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - The cancer proteomic landscape and the HUPO Cancer Proteome Project

AU - Jimenez, Connie R.

AU - Zhang, Hui

AU - Kinsinger, Christopher R.

AU - Nice, Edouard C.

PY - 2018

Y1 - 2018

N2 - The Human Cancer Proteome Project (Cancer-HPP) is an international initiative organized by HUPO whose key objective is to decipher the human cancer proteome through a coordinated effort by cancer proteome researchers around the world. The ultimate goal is to map the entire human cancer proteome to disclose tumor biology and drive improved diagnostics, treatment and management of cancer. Here we report the progress in the cancer proteomics field to date, and discuss future proteomic developments that will be needed to optimally delineate cancer phenotypes and advance the molecular characterization of this significant disease that is one of the leading causes of death worldwide.

AB - The Human Cancer Proteome Project (Cancer-HPP) is an international initiative organized by HUPO whose key objective is to decipher the human cancer proteome through a coordinated effort by cancer proteome researchers around the world. The ultimate goal is to map the entire human cancer proteome to disclose tumor biology and drive improved diagnostics, treatment and management of cancer. Here we report the progress in the cancer proteomics field to date, and discuss future proteomic developments that will be needed to optimally delineate cancer phenotypes and advance the molecular characterization of this significant disease that is one of the leading causes of death worldwide.

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85041474045&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/29416445

U2 - 10.1186/s12014-018-9180-6

DO - 10.1186/s12014-018-9180-6

M3 - Article

VL - 15

JO - Clinical Proteomics

JF - Clinical Proteomics

SN - 1542-6416

IS - 1

M1 - 4

ER -